Companies in Biopharma

See how it works

Browse Biopharma companies with real-time buying signals. Track competitor activity, funding rounds, hiring surges, and product launches across the Biopharma industry.

Discover 2K+ companies in Biopharma

See how it works

Country

United States

United Kingdom

China

France

Canada

PHARMASEAL

Nottingham, United Kingdom · 2016

An Innovative Clinical Trial Management System for Unified Trial Governance used by Biopharma, Med Device & CRO's.

Equity Crowdfunding 11 Biopharma Health Care +1

Alithea Genomics

Lausanne, Switzerland · 2020

Large scale RNA sequencing. Made easy.

Seed 28 Biopharma Biotechnology

PredictImmune

Cambridge, United Kingdom · 2017

PredictImmune creates lab tests to guide personalized treatment for immune-mediated diseases such as IBD.

Grant 2-10 Biopharma Biotechnology +3

Mereo BioPharma

London, United Kingdom · 2015

Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments.

Post Ipo Equity 45 Biopharma Biotechnology +1

Cellestia Biotech

Basel, Switzerland · 2014

Cellestia develops targeted therapies for cancer patients with no other options, including orphan cancers and childhood…

Non Equity Assistance 15 Biopharma Biotechnology +2

eversyn GmbH

Magdeburg, Germany · 2022

Making high-value glycans mainstream.

Seed 5 Biopharma Biotechnology +1

Biomatter

Lithuania · 2018

Creating proteins with Intelligent Architecture™ for health and sustainable manufacturing

Seed 27 Biopharma Biotechnology +2

Healx

Cambridge, United Kingdom · 2014

AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments.

Growth 71 AI Biopharma +3

Turbine

Hungary · 2016

Turbine is virtualizing biological experiments with AI to accelerate drug discovery & enhance clinical translatability.

Series Unknown 117 AI Biopharma +1

Quercis Pharma

Zug, Switzerland · 2019

For a Healthier World

Private Equity 8 Biopharma Biotechnology +2

Vivet Therapeutics

France · 2016

Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using liver tropic virus.

Grant 16 Biopharma Biotechnology +1

Matterhorn Biosciences

Basel, Switzerland · 2020

M-TCR cell therapies targeting a new hallmark of cancer

Series Unknown 7 Biopharma Biotechnology +1

ŌGI Bio

Edinburgh, United Kingdom · 2020

Offering our customers an affordable route into the automation of routine microbial culturing.

Seed 11 Biopharma Biotechnology

Autolus Therapeutics

London, United Kingdom · 2014

Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer

Post Ipo Equity 720 Biopharma Biotechnology +1

Roivant

New York, United States · 2014

Reinventing Biopharma

Unknown 244 Biopharma Biotechnology +2

MultiplAI Health

London, United Kingdom · 2019

MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases.

Seed 11 AI Biopharma +3

Bloomsbury Genetic Therapies

London, United Kingdom · 2021

Dedicated to delivering the promise of gene therapy

Seed 2 Biopharma Biotechnology +1

Adendra Therapeutics

London, United Kingdom · 2021

Translating dendritic cell biology into new therapies for cancer and autoimmunity.

Series A 3 Biopharma Biotechnology +1

Evonetix Ltd

Cambridge, United Kingdom · 2015

Technology to ignite the biology revolution

Series B 11 Biopharma Biotechnology +1

Inspira Pharmaceuticals Limited

London, United Kingdom · 2020

UK biotech focused on preclinical research for diseases of the respiratory tract

Equity Crowdfunding 4 Biopharma Biotechnology +1

Wren Therapeutics

Cambridge, United Kingdom · 2016

Stopping the wave of neurodegeneration at its source

Series Unknown 34 Biopharma Biotechnology +2

See how it works

Track millions of companies and know when they move

Name the companies you care about and we watch them every day, then tell you what changed.

See how it works